Prognia
Drug Database
🇺🇸US · FDA ApprovedDiscontinuedNDA021713-001

ABILIFY(ARIPIPRAZOLE)

Other antipsychotics

Manufacturer: OTSUKA

FDA Approval: 10/12/2004

Route: ORAL · SOLUTION

Active Ingredients

ARIPIPRAZOLE 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ABILIFY — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.